Sofosbuvir Impurity 6
- Molecular Weight: 0
- Update Date: 2023-04-23 13:52:06
What is Sofosbuvir Impurity 6?
The Uses of Sofosbuvir Impurity 6
(2R,3R,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl Benzoate is an intermediate in synthesizing PSI 6130 (P839680), which is an experimental treatment for hepatitis C. PSI 6130 is a member of a class of antiviral drugs known as nucleoside polymerase inhibitors. PSI 6130 inhibits the hepatitis C virus RNA dependant RNA polymerase called NS5B.
Properties of Sofosbuvir Impurity 6
| storage temp. | Refrigerator |
| solubility | DMSO, Methanol |
| form | Solid |
| color | White |
Safety information for Sofosbuvir Impurity 6
Computed Descriptors for Sofosbuvir Impurity 6
New Products
(E)-1-Ethoxyethene-2-boronic Acid Pinacol Ester 1,3-Diethyl-1,3-Diphenylurea 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile Methyl 2-methylquinoline-6-carboxylate 2,4-dihydroxybenzaldehyde 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile 1,3-Di Iodo Benzene Methyl 2-oxo-2,3-dihydrobenzo[d]oxazole-7-carboxylate 4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 3-Hydroxy-4-nitrobromobenzene 2-Ethyl-1,4-diaminobenzene 2-Ethylhexyl 4-aminobenzoate Thio AcetamideRelated products of tetrahydrofuran


You may like
-
MFCD22560726 98%View Details
MFCD22560726 -
3-Hydroxy-4-nitrobromobenzene 98%View Details
2768-84-0 -
4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 98%View Details
1234064-08-4. -
2-Ethyl-1,4-diaminobenzene 98%View Details
MFCD19203885 -
85-81-4 6-Methoxy-8-nitroquinoline 98%View Details
85-81-4 -
2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile 98%View Details -
Hot Sales:Thio AcetamideView Details
62-55-5 -
CosmoticsView Details
26218-04-2
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
